COURTNEY MITCHELL: Open Payments
NPI 1720659204 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,826 in 110 payments from 22 companies in 2025. Trend: 2023 $2,343 · 2024 $1,870 · 2025 $1,826
Food & beverage: $1,826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $294 |
| Novo Nordisk Inc | 24 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $246 |
| PFIZER INC. | 10 | $150 |
| AstraZeneca Pharmaceuticals LP | 2 | $144 |
| Novartis Pharmaceuticals Corporation | 8 | $140 |
| GlaxoSmithKline, LLC. | 5 | $96 |
| Verona Pharma, Inc. | 4 | $76 |
| Teva Pharmaceuticals USA, Inc. | 4 | $72 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
Products named: CAPLYTA, VRAYLAR, LEQVIO, FARXIGA, Ozempic, TRELEGY ELLIPTA, NURTEC ODT, Ohtuvayre.
Industry payments across IN — which companies pay providers there.
